Brief: Curanex Pharmaceuticals Inc - Targets Ind Submission For Phyto-N In Q4 2026
18/03/2026 12:05
March 18 (Reuters) - Curanex Pharmaceuticals Inc CURX.O: CURANEX PHARMACEUTICALS INC - TARGETS IND SUBMISSION FOR PHYTO-N IN Q4 2026 Source text: ID:nGNX2mQtLJ Further company coverage: CURX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Curanex Pharmaceuticals
See all newsBrief: Curanex Pharmaceuticals - Securities Class Action Filed Against Curanex Pharmaceuticals And Underwriters On July 23, 2026 - SEC Filing
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Curanex Pharmaceuticals Advancing Phyto-N Toward A Planned Investigational New Drug Submission To FDA For Ulcerative Colitis In Q4 2026